These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1562020)

  • 1. Potentiation of uremic bleeding by hereditary storage pool disease.
    Berty RM; Zeigler ZR; Bruns FJ
    Am J Kidney Dis; 1992 Apr; 19(4):326-30. PubMed ID: 1562020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin bleeding time for the evaluation of uremic platelet dysfunction and effect of dialysis.
    Soyoral YU; Demir C; Begenik H; Esen R; Kucukoglu ME; Aldemir MN; Demirkiran D; Erkoc R
    Clin Appl Thromb Hemost; 2012; 18(2):185-8. PubMed ID: 22327827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Case of uremic platelet dysfunction].
    Ohzeki M; Fukushima T; Arakawa S; Ozeki M; Kosaka Y; Kobayashi S; Namikoshi T; Haruna Y; Sasaki T; Kashihara N
    Nihon Jinzo Gakkai Shi; 2005; 47(7):834-8. PubMed ID: 16296414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of acquired platelet dysfunctions in uremic and cirrhotic patients using the platelet function analyzer (PFA-100 ): influence of hematocrit elevation.
    Escolar G; Cases A; Viñas M; Pino M; Calls J; Cirera I; Ordinas A
    Haematologica; 1999 Jul; 84(7):614-9. PubMed ID: 10406903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding time in uremia: a useful test to assess clinical bleeding.
    Steiner RW; Coggins C; Carvalho AC
    Am J Hematol; 1979; 7(2):107-17. PubMed ID: 539588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deranged platelet calcium homeostasis in diabetic patients with end-stage renal failure. A possible link to increased cardiovascular mortality?
    Vicari AM; Taglietti MV; Pellegatta F; Spotti D; Melandri M; Galli L; Ronchi P; Folli F
    Diabetes Care; 1996 Oct; 19(10):1062-6. PubMed ID: 8886550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet aggregometry cannot identify uremic platelet dysfunction in heart failure patients prior to cardiac surgery.
    Showalter J; Nguyen ND; Baba S; Lee CH; Ning J; Klein K; Wahed MA; Tholpady A
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27797407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic platelet dysfunction: past and present.
    Escolar G; Díaz-Ricart M; Cases A
    Curr Hematol Rep; 2005 Sep; 4(5):359-67. PubMed ID: 16131436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic disorder of uremia: the platelet defect, main determinant of the prolonged bleeding time, is correlated with indices of activation of coagulation and fibrinolysis.
    Mezzano D; Tagle R; Panes O; Pérez M; Downey P; Muñoz B; Aranda E; Barja P; Thambo S; González F; Mezzano S; Pereira J
    Thromb Haemost; 1996 Sep; 76(3):312-21. PubMed ID: 8883263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic abnormalities in renal disease.
    Jubelirer SJ
    Am J Kidney Dis; 1985 May; 5(5):219-25. PubMed ID: 3923828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole blood platelet aggregation and release reaction testing in uremic patients.
    Zeck J; Schallheim J; Lew SQ; DePalma L
    Biomed Res Int; 2013; 2013():486290. PubMed ID: 23878808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin prolongs bleeding time in uremia by a mechanism distinct from platelet cyclooxygenase inhibition.
    Gaspari F; Viganò G; Orisio S; Bonati M; Livio M; Remuzzi G
    J Clin Invest; 1987 Jun; 79(6):1788-97. PubMed ID: 3108321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation.
    Israels SJ; McNicol A; Robertson C; Gerrard JM
    Br J Haematol; 1990 May; 75(1):118-21. PubMed ID: 2375909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of platelet surface receptor abnormalities in the bleeding and thrombotic diathesis of uremic patients on hemodialysis and peritoneal dialysis.
    Salvati F; Liani M
    Int J Artif Organs; 2001 Mar; 24(3):131-5. PubMed ID: 11314805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis.
    Jørgensen KA; Ingeberg S
    Nephron; 1979; 23(5):233-6. PubMed ID: 481658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimentally induced renal failure in the dog as an animal model of uremic bleeding.
    Brassard JA; Meyers KM; Person M; Dhein CR
    J Lab Clin Med; 1994 Jul; 124(1):48-54. PubMed ID: 8035102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion.
    Cattaneo M; Lecchi A; Agati B; Lombardi R; Zighetti ML
    Thromb Res; 1999 Nov; 96(3):213-7. PubMed ID: 10588464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry.
    Gordon N; Thom J; Cole C; Baker R
    Br J Haematol; 1995 Jan; 89(1):117-23. PubMed ID: 7833250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.